Skip to main content

Clinical Research from Clinical Investigation Services

Call Today to Qualify

Open Hours

Monday – Friday 8 am to 5pm

Have you been diagnosed with Acute Coronary Syndrome (ACS)?

Trial Information:

The LIBREXIA 3003 study by Janssen will study if an experimental drug called milvexian is safe and useful in reducing risk of developing blood clots, stroke, or another heart attach among subjects with a recent heart attack or angina episode, compared to placebo (tablet with no active drug) in addition to standard medication.

Standard medications often prescribed for subjects with a recent heart attack or angina episode may include antiplatelet agents (such as aspirin and other medications that interfere with platelet clumping and thus formation of blood clots), but do not usually include anticoagulants, or blood thinners, that prevent blood clotting through a different mechanism. Milvexian is a type of anticoagulant that may be safer to use than standard anticoagulants for subjects after heart attack or angina episodes.

Dr. Geeta Reddy is the leading physician (called the "principal investigator") for this trial at our affiliate clinic in Libertyville, IL. We are currently accepting new patients for this study.

For more information on this clinical trial, please call us at 847-691-3856 and ask to speak to our recruiter Maria.

Study Protocol: 70033093ACS3003

General Contact Form
Title
When Should We Contact You?
When would it be best for a member of our team to contact you? Please select all that apply.
How Did You Hear About Us?
How did you hear about Clinical Investigation Specialists? Please select all that apply.
If you heard about CIS from someone, please let us know! This field is not required. 
CIS Research is a robust, multi-site network of clinical trial sites. This means we are always running many types of research studies. We would like to contact you if there is a trial that you may be a qualified candidate for in the future. Please tell us a little bit about the types of trials you are interested in.
Please provide any other information you think we should know before a member of our team contacts you.

Dr. Eva Agaiby

President, Director of Clinical Trials & Regulatory Affairs

View Profile

Allen Banoub, MBA

Director of Marketing & Business Development

View Profile